Caroline R. W.
- Country
- France
- Department
- Dermatology
Research Overview
- Evaluation of a Drug Combination in Patients with Cutaneous T-cell Lymphomas (CTCL)
- Phase II Evaluation of Lacutamab Monotherapy and Combination Chemotherapy in Advanced T-Cell Lymphomas, Including Sézary Syndrome and Mycosis Fungoides
- EORTC 1820-CLTF: Open-Label, phase II, Multi-Center, study of Anti-CCR4 Monoclonal Antibody (mogamulizumab) Plus Total Skin Electron Beam therapy (TSEB) in patients with stage IB-IIB Cutaneous T-Cell Lymphoma (MOGAT)
Data & Insights
Has run more than one trial at 10 of 38 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating advanced forms of T-Cell Lymphomas (TCL), with particular emphasis on rare cutaneous manifestations.
- Cutaneous T-Cell Lymphoma (CTCL)
- Sézary Syndrome
- Mycosis Fungoides
Expert focus on managing various stages of disease progression, from early manifestations to advanced presentations.
Therapeutic Innovation
Active involvement in evaluating novel therapeutic approaches for refractory lymphomas, including targeted immunotherapy treatments.
- Monoclonal Antibody Therapy
- Combination Treatment Strategies
- Alternative Dosing Regimens
Dedicated to exploring treatment options for patients with relapsed or resistant disease forms.
Clinical Assessment
Expertise in evaluating treatment responses in advanced lymphoid malignancies, with focus on objective response measurement.
- Response Rate Assessment
- Safety Monitoring
- Long-term Disease Management
Specializes in monitoring treatment efficacy and patient outcomes in challenging cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.